Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Young, GuySrivastava, AlokKavakli, KaanRoss, CecilSathar, JameelaTran, HuyenWu, Runhui2023-01-122023-01-1220210006-49711528-00200006-49711528-0020https://doi.org/10.1182/blood-2021-150273https://hdl.handle.net/11454/77784[No Abstract Available]en10.1182/blood-2021-150273info:eu-repo/semantics/openAccessEfficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)Conference Object138WOS:000736398800005Q1